ArticleJournal of hepatocellular carcinoma2022

Comparison of the Efficacy and Safety of Transarterial Chemoembolization with or without Lenvatinib for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score-Matched Analysis.

Yu-Xing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.